Fixed dose combinations (FDCs) are formulations containing two or more active drugs combined in a fixed ratio. FDCs are justified when they demonstrate benefits like improved therapeutic efficacy, reduced adverse effects, or pharmacokinetic advantages. Rational FDCs can improve compliance for chronic diseases and have better efficacy through synergistic mechanisms. However, irrational FDCs may cause adverse reactions, emergence of resistance, and financial burden. The benefits of FDCs must outweigh the risks like inability to adjust drug doses independently and difficulty identifying the cause of effects. Regulators generally approve FDCs only when alternative single drug options are not available or cost-effective.